- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
The Heartburn Drug market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat a variety of gastrointestinal disorders. Heartburn drugs are used to treat symptoms of gastroesophageal reflux disease (GERD), such as heartburn, acid reflux, and chest pain. These drugs work by reducing the amount of acid produced in the stomach, which helps to reduce the symptoms of GERD. Common types of heartburn drugs include proton pump inhibitors (PPIs), histamine-2 receptor antagonists (H2RAs), and antacids. PPIs are the most commonly prescribed type of heartburn drug, as they are the most effective at reducing acid production.
Some companies in the Heartburn Drug market include AstraZeneca, GlaxoSmithKline, Pfizer, Merck, and Takeda. Show Less Read more